Dichotomous roles of co-stimulatory molecules in diabetes mellitus

Oncotarget. 2017 Dec 7;9(2):2902-2911. doi: 10.18632/oncotarget.23102. eCollection 2018 Jan 5.

Abstract

Numerous studies have established the importance of immune dysfunction in the development of diabetes mellitus, including typ1 and typ2 diabetes, and it is worth noting that T cell activation acts a key role in the pathogenesis of loss of β cell mass, adipose inflammation and insulin resistance. Regarding as an important checkpoint in the process of T cell activation, co-stimulatory molecules interaction between antigen present cells and T cells have been identified the critical role in the development of diabetes mellitus. Thus, blockage of co-stimulatory dyads interaction between antigen present cells and T cells was supposed to a potential of therapeutic strategies. However, studies also showed that inhibition or deletion of some co-stimulatory molecules do not always reduce the development of diabetes, and even exacerbate the disease activity. Here, in this context, we highlight the dichotomous role of co-stimulatory molecules interaction in the pathogenesis of diabetes.

Keywords: CD28; co-stimulatory molecule; dendritic cells; diabetes mellitus; macrophage.

Publication types

  • Review